x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- Cai, TianxiRemove Cai, Tianxi filter
- Koch, ManjaRemove Koch, Manja filter
- epidemiologyRemove epidemiology filter
Publication Date
Please choose a date range between 2017 and 2020.
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia
Journal of Lipid ResearchVol. 61Issue 3p445–454Published online: December 31, 2019- Manja Koch
- Steven T. DeKosky
- Matthew Goodman
- Jiehuan Sun
- Jeremy D. Furtado
- Annette L. Fitzpatrick
- and others
Cited in Scopus: 10Whether HDL is associated with dementia risk is unclear. In addition to apoA1, other apolipoproteins are found in HDL, creating subspecies of HDL that may have distinct metabolic properties. We measured apoA1, apoC3, and apoJ levels in plasma and apoA1 levels in HDL that contains or lacks apoE, apoJ, or apoC3 using a modified sandwich ELISA in a case-cohort study nested within the Ginkgo Evaluation of Memory Study. We included 995 randomly selected participants and 521 participants who developed dementia during a mean of 5.1 years of follow-up. - Patient-Oriented and Epidemiological ResearchOpen Access
Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III
Journal of Lipid ResearchVol. 58Issue 6p1196–1203Published online: April 1, 2017- Manja Koch
- Jeremy D. Furtado
- Gordon Z. Jiang
- Brianna E. Gray
- Tianxi Cai
- Frank Sacks
- and others
Cited in Scopus: 16The presence of apoC-III on HDL impairs HDL's inverse association with coronary heart disease (CHD). Little is known about modifiable factors explaining variation in HDL subspecies defined according to apoC-III. The aim was to investigate cross-sectional associations of anthropometry and lifestyle with HDL subspecies in 3,631 participants from the Diet, Cancer, and Health study originally selected for a case-cohort study (36% women; age 50–65 years) who were all free of CHD. Greater adiposity and less activity were associated with higher HDL containing apoC-III and lower HDL lacking apoC-III.